跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cresemba - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cresemba
Approved
STANDARD
Cresemba
Baxter Pharmaceutical Solutions LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1857eb27e52c51e2
Company
Baxter Pharmaceutical Solutions LLC
Type
Standard
Approval Details
Approval Id
1857eb27e52c51e2
Drug Approval Philippines Name
Cresemba
Product Name
Cresemba
Registration Number
DR-XY47831
Brand Name
Cresemba
Generic Name
Isavuconazonium Sulfate
Dosage Form
Lyophilized Powder for Concentrate for Solution for I.V. Infusion
Dosage Strength
372.6 mg (equivalent to 200 mg Isa vuconazole)
Manufacturer
Baxter Pharmaceutical Solutions LLC
Importer
Pfizer, Inc.
Company Detail Path
/organization/baxter-pharmaceutical-solutions-llc
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
30 March 2022
Expiry Date
30 March 2027
Pharmacologic Category
Antifungal
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1857eb27e52c51e2
Type
Standard
Back to Philippines FDA Approvals